Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Corp.

June 06, 2005 15:48 ET

Forum Alert: Stem Cell Therapeutics will Present at the Informed Investors Biotechnology-Healthcare-Pharmaceutical Investor Forum on Tuesday, June 15, 2005, 3:10 pm ET

CALGARY, ALBERTA--(CCNMatthews - June 6, 2005) -

To Be Held at The Princeton Club of New York

Stem Cell Therapeutics (TSX:SSS.V) will present at the following forum:

What: Informed Investors Biotechnology / Healthcare / Pharmaceutical
Investor Forum

When: June 15, 2005 @ 3:10 PM Eastern Time

Sponsors: Barron's, The Wall Street Journal, The American Stock
Exchange and Business Wire

Presentations: Lynn Sutherland, M.S., M.B.A. - President, Sutherland
Dr. Navdeep Jaikaria, Senior Biotechnology Analyst,
Rodman & Renshaw, LLC

Where: The Princeton Club of New York, 15 West 43rd Street.,
New York City, NY 10036

How to
attend: Pre-registration is necessary. To register, contact Cary
Loeser,, or 804-327-3407. You may also
call Customer Service at 888-301-6618, or register at the
following link:

If you are unable to attend the live event, the forum will be
available via webcast at

Contact: Dr. Joseph Tucker,,
(403) 245-5495

Stem Cell Therapeutics Corp. is a biotechnology company focused on the development of its technology platform and intellectual property to selectively induce a patient's own stem cells to proliferate in the brain. SCT's core technology, which includes its lead therapeutic product NTx™-265, has been demonstrated to increase the number of innate adult stem cells that grow in place when this therapeutic approach is applied to test animals. This fundamental technology will be further developed to create specific disease treatments for stroke, Huntington's disease, Alzheimer's disease and other neurodegenerative conditions.

Source: Stem Cell Therapeutics

Contact Information